生物活性 | |||
---|---|---|---|
描述 | DSR-6434 is a highly potent TLR7 agonist with EC50 value of 7.2nM for activation of hTLR7 in NF-κB SEAP reporter assay. Administration of DSR-6434, i.v., inhibited lung metastasis by 78% at dose of 0.1mg/kg and suppressed lung metastasis completely at dose of 1 mg/kg on HM-1 metastasis model. DSR-6434 at concentration<5μM alone does not affect tumor cell( CT26 or KHT) clonogenic potential or radio sensitivity in vitro. Intravenous administration of 0.1mg/kg DSR-6434 in combination with IR improved survival in syngeneic models of colorectal carcinoma and fibrosarcoma in vivo, which may due to priming an antitumor CD8+ T-cell response. | ||
作用机制 | DSR-6434 possesses 8-oxoadenine structure which is a novel structural class IFN inducer.[1] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.50mL 0.50mL 0.25mL |
12.49mL 2.50mL 1.25mL |
24.97mL 4.99mL 2.50mL |
参考文献 |
---|